Cyproterone acetate, ethinyl estradiol drug combination
Showing 9976 - 10000 of >10,000
Human Papilloma Virus, Recurrent Respiratory Papillomatosis Trial in Boston (Lenvatinib, Pembrolizumab)
Not yet recruiting
- Human Papilloma Virus
- Recurrent Respiratory Papillomatosis
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Dec 10, 2021
Oligodendroglioma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)
Recruiting
- Oligodendroglioma
- Tislelizumab plus Bevacizumab
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Aug 21, 2022
Tuberculosis Trial in United States (Rifapentine (RPT))
Completed
- Tuberculosis
- Rifapentine (RPT)
-
San Diego, California
- +3 more
Nov 4, 2021
Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,
Suspended
- Burkitt Lymphoma
- +4 more
- Rituximab
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in
Recruiting
- Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
- Chronic Lung Allograft Dysfunction
- Sirolimus
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 28, 2023
Tourette Syndrome Trial in São Paulo (Deep Brain Stimulation (DBS), Sham Stimulation)
Active, not recruiting
- Tourette Syndrome
- Deep Brain Stimulation (DBS)
- Sham Stimulation
-
São Paulo, Sao Paulo, BrazilUniversity of São Paulo
Jun 7, 2022
Plasma Concentration of Ceftazidime-Avibactam in Critically Ill
Recruiting
- Severe Sepsis
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine,Zhejiang Unive
Jun 7, 2022
Temocillin in ESBL-Enterobacteriaceae Infections
Not yet recruiting
- Infectious Disease
- Temocillin
- (no location specified)
Jun 7, 2022
FimasaRtan-basEd BP Targets After Drug SwitcHing
Completed
- Essential Hypertension
-
Suwon, Korea, Republic ofAjou University Hospital
Dec 22, 2020
Diabetic Nephropathy Trial in Worldwide (Nidufexor, Placebo, Standard of Care (SoC))
Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)
Active, not recruiting
- Chronic Hepatitis B
- VIR-2218
- pegylated interferon-alfa 2a
-
Birtinya, Queensland, Australia
- +21 more
Dec 20, 2021
Mydriasis Trial in Cypress (Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE), Tropicamide 1% ophthalmic solution
Completed
- Mydriasis
- Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)
- +2 more
-
Cypress, CaliforniaWCCT
Mar 16, 2022
Periodontitis, Periodontal Pocket Trial in Belo Horizonte (Amoxicillin 500 milligrams capsules plus metronidazole 400
Enrolling by invitation
- Periodontitis
- Periodontal Pocket
- Amoxicillin 500 milligrams capsules plus metronidazole 400 milligrams
- placebo
-
Belo Horizonte, Minas Gerais, BrazilFederal University of Minas Gerais, Dental School
Jun 28, 2023
Critical Limb Ischemia, Peripheral Arterial Disease Trial in Worldwide (DCB, PTA)
Active, not recruiting
- Critical Limb Ischemia
- Peripheral Arterial Disease
- DCB
- PTA
-
Dendermonde, East-Flanders, Belgium
- +9 more
Dec 21, 2021
Patients Referred toSubstance Abuse Liaison Department
Recruiting
- Substance Abuse
- +3 more
-
Amiens, FranceCHU Amiens
Jun 7, 2021
Cystic Fibrosis Trial in London (ETD001 single dose, Placebo single dose, ETD001 multiple twice daily doses)
Completed
- Cystic Fibrosis
- ETD001 single dose
- +5 more
-
London, United KingdomHammersmith Medicines Research
Mar 23, 2022
Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)
Not yet recruiting
- Salivary Duct Carcinoma
- Goserelin 10.8 mg
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 23, 2022
Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,
Completed
- Stable Angina
- +2 more
- 3-months DAPT
- 1-year DAPT
-
Busan, Korea, Republic of
- +11 more
Jan 8, 2023
Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)
Recruiting
- Solid Tumor
- Hematologic Malignancy
- Eliglustat
- Immune checkpoint inhibitor
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Apr 28, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)
Recruiting
- Ewing Sarcoma
- +10 more
- Seclidemstat
- +2 more
-
Los Angeles, California
- +16 more
Jan 18, 2022
Low Back Pain, Chronic Low-back Pain Trial in Villaviciosa De Odón, Alcorcón (tDCS and aerobic exercise)
Recruiting
- Low Back Pain
- Chronic Low-back Pain
- tDCS and aerobic exercise
-
Villaviciosa De Odón, Madrid, Spain
- +1 more
Apr 14, 2023
Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)
Active, not recruiting
- Acute Myeloid Leukemia
-
Baltimore, Maryland
- +2 more
May 19, 2022
Postprandial Hyperglycemia on Vasculature in DM1 and Healthy
Recruiting
- Type 1 Diabetes
- Hyperglycemia, Postprandial
- Mixed Meal
-
Charlottesville, VirginiaUniversity of Virginia
Oct 5, 2022
Gastroesophageal Cancer, Adenocarcinoma Trial in United States (Pembrolizumab, Abemaciclib)
Active, not recruiting
- Gastroesophageal Cancer
- Adenocarcinoma
-
Indianapolis, Indiana
- +3 more
Feb 16, 2022
Catheter Complications Trial in Toulouse (Clinical pharmacy activities along the care pathways)
Recruiting
- Catheter Complications
- Clinical pharmacy activities along the care pathways
-
Toulouse, Occitanie, FranceCIVADE
Jun 8, 2022